AstraZeneca moves finance chief Dunoyer to head Alexion
AstraZeneca will move finance chief Marc Dunoyer to head newly acquired rare diseases business Alexion, using the $39 billion takeover as an opportunity to freshen up a management team that had been in place for eight years.
Business
• 04 Jun 21
